A proposed FDA rule could fundamentally change how new food ingredients enter the U.S. marketplace.

In Episode 133 of the Orange Pill Podcast, we unpack the FDA's proposal to move from voluntary to mandatory GRAS notifications, and explore what this shift could mean for food innovation, regulatory transparency, consumer safety, and the future of ingredient development.

Millions of people struggle with constipation, yet many still rely on laxatives that simply force the digestive system into action.

In Episode 132 of the Orange Pill Podcast, we explore why fructooligosaccharides (FOS), a clinically studied prebiotic, may represent a smarter approach to digestive health.

Learn how FOS nourishes beneficial gut bacteria, promotes natural bowel function, and supports long-term digestive wellness through the power of the microbiome.

Clinical trials are essential, but choosing the wrong dose, population, or endpoint can derail a study before it begins.

In Episode 131 of the Orange Pill Podcast, we introduce the KGK Design Intelligence Lab and explore how in silico dietary modeling can simulate health outcomes across virtual populations before the first participant is enrolled.

By combining randomized clinical trial data, NHANES population insights, and advanced statistical modeling, researchers can design smarter, more targeted, and better-informed human studies.

Can one of the world's most researched plant compounds actually improve athletic performance, or have we been asking the wrong question?

In this episode of the Orange Pill Podcast, we explore the science behind quercetin, the flavonoid once hailed as an "exercise mimetic" after remarkable animal studies.

Discover why early human trials largely disappointed, how new delivery technologies are changing the conversation, and why quercetin's greatest benefit may not be improving race-day performance, but helping athletes recover faster and train harder.

For decades, America's food innovation system has relied on the self-GRAS pathway, allowing companies to determine the safety of new ingredients without mandatory FDA notification.

That system may be about to change.

In this episode of the Orange Pill Podcast, we explore the proposed federal legislation that could fundamentally reshape how food ingredients reach the marketplace, and what it means for manufacturers, regulators, and consumers alike.

Why do two people eating the exact same meal have completely different metabolic responses?

In this episode of the Orange Pill Podcast, we explore the groundbreaking PREDICT study, the largest personalized nutrition study of its kind, which challenges decades of conventional dietary advice.

From your gut microbiome and meal timing to machine learning and metabolic fingerprints, discover why the future of nutrition may be far more personal than we've ever imagined.

A new Utah law is expanding the definition of "specialized products", and the implications could extend well beyond cannabinoids and nicotine.

In this episode of the Orange Pill Podcast, we unpack H.B. 385, the legislation introducing new licensing, testing, and reporting requirements for products with psychoactive, sedative, or analgesic properties.

From melatonin and botanicals to retailer liability and product transparency, we explore what this law could mean for the future of supplement regulation in the United States.

Feeling "fine" isn't always the same as feeling your best.

In this episode of the Orange Pill Podcast, we explore groundbreaking research showing how a standardized saffron extract may improve perceived mental well-being, not by acting like an antidepressant, but by subtly reshaping the body's chemistry.

From metabolomics and amino acid pathways to stress resilience and preventive mental health, this episode uncovers why the future of mood support may begin long before a clinical diagnosis.

The push to "Make America Healthy Again" promised sweeping changes to the U.S. food supply, but turning bold ideas into federal policy is proving far more complex.

In this episode of the Orange Pill Podcast, we explore the growing debate around food additives, GRAS reform, food dyes, and the influence of lobbying on regulatory decision-making.

As policymakers, industry, and consumer advocates collide, one question remains: how do we modernize food regulation while balancing innovation, scientific evidence, and public health?

Migraine is more than a headache- it is one of the leading causes of disability worldwide and the number one cause of disability among children and adolescents.

In this episode of the Orange Pill Podcast, we explore the growing body of research linking magnesium deficiency to migraine risk, severity, and neurological health.

From hidden deficiencies and energy metabolism to emergency room interventions and long-term prevention, this episode examines why one of the body's most overlooked minerals is becoming a major focus in migraine science.